Interaction of Graphene Oxide Particles and Dendrimers with Human Breast Cancer Cells by Real-Time Microscopy

Overview

Journal Pharmaceutics

Publisher MDPI

Date 2023 Dec 23

PMID 38139996

Authors

Beatriz Fumelli Monti Ribeiro

Julyane Batista Chaves

Marcelo Medina de Souza

Artur Franz Keppler

Devaney Ribeiro Do Carmo

Glaucia M Machado-Santelli

Affiliations

Soon will be listed here.

Abstract

Graphene oxide (GOX) has become attractive due to its unique physicochemical properties. This nanomaterial can associate with other dendrimers, making them more soluble and allowing better interaction with biomacromolecules. The present study aimed to investigate, by real-time microscopy, the behavior of human breast cancer cells exposed to particles of materials based on graphene oxide. The MCF-7 cell line was exposed to GOX, GOX associated with Polypropylenimine hexadecaamine Dendrimer, Generation 3.0-DAB-AM-16 (GOXD) and GOX associated with polypropyleneimine-PAMAM (GOXP) in the presence or absence of fetal bovine serum (FBS). GOX, GOXD and GOXP were taken up by the cells in clusters and then the clusters were fragmented into smaller ones inside the cells. Real-time microscopy showed that the presence of FBS in the culture medium could allow a more efficient internalization of graphene materials. After internalizing the materials, cells can redistribute the clumps to their daughter cells. In conclusion, the present study showed that the particles can adhere to the cell surface, favoring their internalization. The presence of FBS contributed to the formation of smaller aggregates of particles, avoiding the formation of large ones, and thus transmitted a more efficient internalization of the materials through the interaction of the particles with the cell membrane.

References

Sun X, Zhao P, Lin J, Chen K, Shen J . Recent advances in access to overcome cancer drug resistance by nanocarrier drug delivery system. Cancer Drug Resist. 2023; 6(2):390-415. PMC: 10344729. DOI: 10.20517/cdr.2023.16. View

Jensen C, Teng Y . Is It Time to Start Transitioning From 2D to 3D Cell Culture?. Front Mol Biosci. 2020; 7:33. PMC: 7067892. DOI: 10.3389/fmolb.2020.00033. View

Malik S, Mohanta Z, Srivastava C, Atreya H . Modulation of protein-graphene oxide interactions with varying degrees of oxidation. Nanoscale Adv. 2022; 2(5):1904-1912. PMC: 9419239. DOI: 10.1039/c9na00807a. View

Chatterjee N, Eom H, Choi J . A systems toxicology approach to the surface functionality control of graphene-cell interactions. Biomaterials. 2013; 35(4):1109-27. DOI: 10.1016/j.biomaterials.2013.09.108. View

Liu N, Tang M, Ding J . The interaction between nanoparticles-protein corona complex and cells and its toxic effect on cells. Chemosphere. 2019; 245:125624. DOI: 10.1016/j.chemosphere.2019.125624. View

Geim A, Novoselov K . The rise of graphene. Nat Mater. 2007; 6(3):183-91. DOI: 10.1038/nmat1849. View

Li J, Zeng H, Zeng Z, Zeng Y, Xie T . Promising Graphene-Based Nanomaterials and Their Biomedical Applications and Potential Risks: A Comprehensive Review. ACS Biomater Sci Eng. 2021; 7(12):5363-5396. DOI: 10.1021/acsbiomaterials.1c00875. View

Rennick J, Johnston A, Parton R . Key principles and methods for studying the endocytosis of biological and nanoparticle therapeutics. Nat Nanotechnol. 2021; 16(3):266-276. DOI: 10.1038/s41565-021-00858-8. View

Han X, Zheng K, Wang R, Yue S, Chen J, Zhao Z . Functionalization and optimization-strategy of graphene oxide-based nanomaterials for gene and drug delivery. Am J Transl Res. 2020; 12(5):1515-1534. PMC: 7270027. View

10.

Marichal L, Giraudon-Colas G, Cousin F, Thill A, Labarre J, Boulard Y . Protein-Nanoparticle Interactions: What Are the Protein-Corona Thickness and Organization?. Langmuir. 2019; 35(33):10831-10837. DOI: 10.1021/acs.langmuir.9b01373. View

11.

Behzadi S, Serpooshan V, Tao W, Hamaly M, Alkawareek M, Dreaden E . Cellular uptake of nanoparticles: journey inside the cell. Chem Soc Rev. 2017; 46(14):4218-4244. PMC: 5593313. DOI: 10.1039/c6cs00636a. View

12.

Huang J, Zong C, Shen H, Liu M, Chen B, Ren B . Mechanism of cellular uptake of graphene oxide studied by surface-enhanced Raman spectroscopy. Small. 2012; 8(16):2577-84. DOI: 10.1002/smll.201102743. View

13.

Novoselov K, Geim A, Morozov S, Jiang D, Zhang Y, Dubonos S . Electric field effect in atomically thin carbon films. Science. 2004; 306(5696):666-9. DOI: 10.1126/science.1102896. View

14.

Dabrowski B, Zuchowska A, Brzozka Z . Graphene oxide internalization into mammalian cells - a review. Colloids Surf B Biointerfaces. 2022; 221:112998. DOI: 10.1016/j.colsurfb.2022.112998. View

15.

Lu H, Stenzel M . Multicellular Tumor Spheroids (MCTS) as a 3D In Vitro Evaluation Tool of Nanoparticles. Small. 2018; 14(13):e1702858. DOI: 10.1002/smll.201702858. View

16.

Dias A, da Silva Santos S, da Silva J, Parise-Filho R, Ferreira E, El Seoud O . Dendrimers in the context of nanomedicine. Int J Pharm. 2019; 573:118814. DOI: 10.1016/j.ijpharm.2019.118814. View

17.

Rivera-Gil P, Jimenez de Aberasturi D, Wulf V, Pelaz B, Del Pino P, Zhao Y . The challenge to relate the physicochemical properties of colloidal nanoparticles to their cytotoxicity. Acc Chem Res. 2012; 46(3):743-9. DOI: 10.1021/ar300039j. View

18.

Wang F, Yu L, Monopoli M, Sandin P, Mahon E, Salvati A . The biomolecular corona is retained during nanoparticle uptake and protects the cells from the damage induced by cationic nanoparticles until degraded in the lysosomes. Nanomedicine. 2013; 9(8):1159-68. DOI: 10.1016/j.nano.2013.04.010. View

19.

Vacchi I, Guo S, Raya J, Bianco A, Menard-Moyon C . Strategies for the Controlled Covalent Double Functionalization of Graphene Oxide. Chemistry. 2020; 26(29):6591-6598. DOI: 10.1002/chem.201905785. View

20.

Pourjavadi A, Asgari S, Hosseini S, Akhlaghi M . Codelivery of Hydrophobic and Hydrophilic Drugs by Graphene-Decorated Magnetic Dendrimers. Langmuir. 2018; 34(50):15304-15318. DOI: 10.1021/acs.langmuir.8b02710. View